Soleno Therapeutics (SLNO) News Today $64.27 +0.51 (+0.80%) Closing price 04:00 PM EasternExtended Trading$64.29 +0.02 (+0.03%) As of 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SLNO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO5 hours ago | prnewswire.comSoleno Therapeutics appoints Hahn to its board of directorsOctober 13 at 1:36 PM | msn.comSoleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of DirectorsOctober 13 at 8:34 AM | finance.yahoo.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsOctober 12 at 5:09 PM | globenewswire.comNationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Takes $42.09 Million Position in Soleno Therapeutics, Inc. $SLNOOctober 12 at 5:55 AM | marketbeat.comTD Cowen Keeps Their Buy Rating on Soleno Therapeutics (SLNO)October 11 at 12:34 AM | theglobeandmail.comSoleno:Â Blockbuster Launch In ProgressOctober 11 at 9:06 AM | seekingalpha.comSoleno Therapeutics (NASDAQ:SLNO) Upgraded at The Goldman Sachs GroupOctober 10 at 7:28 AM | marketbeat.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsOctober 9, 2025 | globenewswire.comSoleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens BermanOctober 9, 2025 | globenewswire.comSOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Soleno Therapeutics, Inc. and Encourages Investors to Contact the FirmOctober 9, 2025 | globenewswire.comSoleno Therapeutics (NASDAQ:SLNO) Given Sell (D-) Rating at Weiss RatingsOctober 9, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOOctober 8, 2025 | prnewswire.comPiper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PTOctober 8, 2025 | finance.yahoo.comSoleno Therapeutics initiated with a Buy at Goldman SachsOctober 7, 2025 | msn.comSoleno Therapeutics (SLNO): Reassessing Valuation After VYKAT XR Safety Debate and Analyst SupportOctober 7, 2025 | finance.yahoo.comSoleno rated as new Buy at Goldman Sachs on Vykat XR potentialOctober 7, 2025 | msn.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 7% - Should You Buy?October 7, 2025 | marketbeat.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsOctober 6, 2025 | globenewswire.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOOctober 5, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOOctober 3, 2025 | prnewswire.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsOctober 2, 2025 | globenewswire.comSoleno Therapeutics (NASDAQ:SLNO) Trading Down 9% - Here's WhyOctober 1, 2025 | marketbeat.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOSeptember 30, 2025 | prnewswire.comWells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123September 30, 2025 | msn.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 29, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 28, 2025 | prnewswire.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 26, 2025 | globenewswire.comSOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the FirmSeptember 25, 2025 | globenewswire.comSoleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens BermanSeptember 25, 2025 | globenewswire.comSoleno Therapeutics (SLNO) Jumps 13.46% as Competitor Fails Prader-Willi Treatment TrialSeptember 25, 2025 | insidermonkey.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOSeptember 24, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 24, 2025 | globenewswire.comAcadia slumps after trial setback for Prader-Willi syndrome drug; Soleno jumpsSeptember 24, 2025 | msn.comSoleno Therapeutics stock jumps after rival’s Prader-Willi drug fails trialSeptember 24, 2025 | za.investing.comSoleno Therapeutics Shares Surge After Competitor’s Prader-Willi Treatment Misses EndpointSeptember 24, 2025 | msn.comSoleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - What's Next?September 24, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 24, 2025 | globenewswire.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 23, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 23, 2025 | prnewswire.comAssenagon Asset Management S.A. Lowers Position in Soleno Therapeutics, Inc. $SLNOSeptember 23, 2025 | marketbeat.comRosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - SLNOSeptember 22, 2025 | prnewswire.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by AnalystsSeptember 22, 2025 | marketbeat.comSLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsSeptember 20, 2025 | globenewswire.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Short Interest UpdateSeptember 19, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 9.5% - Still a Buy?September 19, 2025 | marketbeat.comSOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the FirmSeptember 18, 2025 | globenewswire.comSoleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens BermanSeptember 18, 2025 | globenewswire.comSoleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR ExpandsSeptember 18, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNOSeptember 18, 2025 | prnewswire.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.380.77▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼228▲SLNO Articles Average Week Get the Latest News and Ratings for SLNO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Soleno Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Femasys News Immunovant News Penumbra News Stevanato Group News iRhythm Technologies News Bausch + Lomb News Glaukos News TransMedics Group News Envista News LivaNova News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
